140 related articles for article (PubMed ID: 7847670)
1. Neurodegenerative disease: autoimmunity involving calcium channels.
Appel SH; Smith RG; Alexianu M; Engelhardt J; Mosier D; Colom L; Stefani E
Ann N Y Acad Sci; 1994 Dec; 747():183-94. PubMed ID: 7847670
[No Abstract] [Full Text] [Related]
2. Antibodies to L-type calcium channels in amyotrophic lateral sclerosis.
Wierzbicki AS
N Engl J Med; 1993 May; 328(18):1355-6; author reply 1356-7. PubMed ID: 8385743
[No Abstract] [Full Text] [Related]
3. Antibodies to L-type calcium channels in amyotrophic lateral sclerosis.
Engel WK
N Engl J Med; 1993 May; 328(18):1356; author reply 1356-7. PubMed ID: 8385744
[No Abstract] [Full Text] [Related]
4. Amyotrophic lateral sclerosis and autoimmunity.
Rowland LP
N Engl J Med; 1992 Dec; 327(24):1752-3. PubMed ID: 1331792
[No Abstract] [Full Text] [Related]
5. Amyotrophic lateral sclerosis patient antibodies label Ca2+ channel alpha 1 subunit.
Kimura F; Smith RG; Delbono O; Nyormoi O; Schneider T; Nastainczyk W; Hofmann F; Stefani E; Appel SH
Ann Neurol; 1994 Feb; 35(2):164-71. PubMed ID: 8109897
[TBL] [Abstract][Full Text] [Related]
6. Immunoassays fail to detect antibodies against neuronal calcium channels in amyotrophic lateral sclerosis serum.
Arsac C; Raymond C; Martin-Moutot N; Dargent B; Couraud F; Pouget J; Seagar M
Ann Neurol; 1996 Nov; 40(5):695-700. PubMed ID: 8957009
[TBL] [Abstract][Full Text] [Related]
7. Serum antibodies to L-type calcium channels in patients with amyotrophic lateral sclerosis.
Smith RG; Hamilton S; Hofmann F; Schneider T; Nastainczyk W; Birnbaumer L; Stefani E; Appel SH
N Engl J Med; 1992 Dec; 327(24):1721-8. PubMed ID: 1331790
[TBL] [Abstract][Full Text] [Related]
8. Amyotrophic lateral sclerosis immunoglobulins increase Ca2+ currents in a motoneuron cell line.
Mosier DR; Baldelli P; Delbono O; Smith RG; Alexianu ME; Appel SH; Stefani E
Ann Neurol; 1995 Jan; 37(1):102-9. PubMed ID: 7818241
[TBL] [Abstract][Full Text] [Related]
9. [Calcium, neuronal death and neurological disease].
Jiménez-Jiménez FJ; García-Ruiz PJ; de Bustos F
Rev Neurol; 1996 Oct; 24(134):1199-209. PubMed ID: 8983715
[TBL] [Abstract][Full Text] [Related]
10. Amyotrophic lateral sclerosis: hypothetical pathogenesis.
Brown DW
Med Hypotheses; 1994 Jun; 42(6):393-4. PubMed ID: 7523840
[TBL] [Abstract][Full Text] [Related]
11. Antibodies from ALS patients inhibit dopamine release mediated by L-type calcium channels.
Benatar M
Neurology; 1999 Apr; 52(7):1520-1. PubMed ID: 10227659
[No Abstract] [Full Text] [Related]
12. Amyotrophic lateral sclerosis and antibodies to voltage-gated calcium channels--new doubts.
Vincent A; Drachman DB
Ann Neurol; 1996 Nov; 40(5):691-3. PubMed ID: 8957007
[No Abstract] [Full Text] [Related]
13. Autoimmunity and ALS: a comparison of animal models of immune-mediated motor neuron destruction and human ALS.
Appel SH; Engelhardt JI; García J; Stefani E
Adv Neurol; 1991; 56():405-12. PubMed ID: 1853774
[No Abstract] [Full Text] [Related]
14. [Hope for amyotrophic lateral sclerosis?].
Jokelainen M
Duodecim; 1994; 110(16):1499-501. PubMed ID: 7497973
[No Abstract] [Full Text] [Related]
15. [Immunological aspects of amyotrophic lateral sclerosis].
Yoshino H
Nihon Rinsho; 1994 Nov; 52(11):2984-9. PubMed ID: 7996698
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxicity of immunoglobulins from amyotrophic lateral sclerosis patients on a hybrid motoneuron cell line.
Smith RG; Alexianu ME; Crawford G; Nyormoi O; Stefani E; Appel SH
Proc Natl Acad Sci U S A; 1994 Apr; 91(8):3393-7. PubMed ID: 8159758
[TBL] [Abstract][Full Text] [Related]
17. Anti-calcium channel autoantibodies in amyotrophic lateral sclerosis. A review of the evidence.
Seagar MJ; Martin-Moutot N; Leveque C; Marqueze B; Pouget J
Adv Neurol; 1995; 68():67-72. PubMed ID: 8787244
[No Abstract] [Full Text] [Related]
18. Proteolytic activity in amyotrophic lateral sclerosis IgG preparations.
Nyormoi O
Ann Neurol; 1996 Nov; 40(5):701-6. PubMed ID: 8957010
[TBL] [Abstract][Full Text] [Related]
19. A unifying hypothesis for the cause of amyotrophic lateral sclerosis, parkinsonism, and Alzheimer disease.
Appel SH
Ann Neurol; 1981 Dec; 10(6):499-505. PubMed ID: 6173010
[TBL] [Abstract][Full Text] [Related]
20. Antibodies from ALS patients inhibit dopamine release mediated by L-type calcium channels.
Offen D; Halevi S; Orion D; Mosberg R; Stern-Goldberg H; Melamed E; Atlas D
Neurology; 1998 Oct; 51(4):1100-3. PubMed ID: 9781536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
